Loading clinical trials...
Loading clinical trials...
Evaluation of the Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders: Monocentric Observational and Cross-sectional Study.
Conditions
Interventions
Bortezomib
Locations
1
France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Start Date
January 15, 2019
Primary Completion Date
December 31, 2019
Completion Date
January 31, 2020
Last Updated
November 12, 2020
NCT06152575
NCT06179888
NCT04973605
NCT05201781
NCT05862012
NCT06138275
Lead Sponsor
University Hospital, Clermont-Ferrand
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions